Your Shopping Cart
By using this site you agree to our use of cookies. Please refer to our privacy policy for more information. Close
Undeclared Allergen Whey Triggers Recall of Chicken Tamales in California
- Date: December 09, 2010
- Source: Admin
California Firm, Diana’s Mexican Food Products, Inc. has announced the recall of around 41,670 pounds of chicken tamales. The recall was triggered due to the presence of an undeclared allergen, whey. The company had not declared the same on the label.
The U.S. Department of Agriculture's (USDA) Food Safety and Inspection Service (FSIS) made the announcement regarding the recall. Routine inspection by the FSIS brought this discrepancy up.
It is mandatory for companies to provide appropriate labeling of their products with a listing of allergenic ingredients. Therefore, companies are strongly encouraged to declare any allergenic ingredient contained in a spice, flavor, or color.
The violation
The non declaration of whey is a violation of Section 403(i)(2) of the Federal Food, Drug, and Cosmetic Act (the Act).
Products that contain an allergenic ingredient by design must comply with section 403(i)(2) of the Federal Food, Drug, and Cosmetic Act (the Act), which requires each ingredient in a food to be declared. Processing aids that contain allergenic ingredients must be declared in accordance with 21 CFR 101.4(a)(1). Production practices that lead to unintentional addition of allergens to food may be considered insanitary conditions that may render the food injurious to health and cause the food product to be adulterated under section 402(a)(4) of the Act.
USDA Recall Classifications
The recall is a USDA Class I recall posing high health risks.
Class I: This is a health hazard situation where there is a reasonable probability that the use of the product will cause serious, adverse health consequences or death.
Class II: This is a health hazard situation where there is a remote probability of adverse health consequences from the use of the product.
Class III: This is a situation where the use of the product will not cause adverse health consequences.
The U.S. Department of Agriculture's (USDA) Food Safety and Inspection Service (FSIS) made the announcement regarding the recall. Routine inspection by the FSIS brought this discrepancy up.
It is mandatory for companies to provide appropriate labeling of their products with a listing of allergenic ingredients. Therefore, companies are strongly encouraged to declare any allergenic ingredient contained in a spice, flavor, or color.
The violation
The non declaration of whey is a violation of Section 403(i)(2) of the Federal Food, Drug, and Cosmetic Act (the Act).
Products that contain an allergenic ingredient by design must comply with section 403(i)(2) of the Federal Food, Drug, and Cosmetic Act (the Act), which requires each ingredient in a food to be declared. Processing aids that contain allergenic ingredients must be declared in accordance with 21 CFR 101.4(a)(1). Production practices that lead to unintentional addition of allergens to food may be considered insanitary conditions that may render the food injurious to health and cause the food product to be adulterated under section 402(a)(4) of the Act.
USDA Recall Classifications
The recall is a USDA Class I recall posing high health risks.
Class I: This is a health hazard situation where there is a reasonable probability that the use of the product will cause serious, adverse health consequences or death.
Class II: This is a health hazard situation where there is a remote probability of adverse health consequences from the use of the product.
Class III: This is a situation where the use of the product will not cause adverse health consequences.
Source
Compliance Trainings
How FDA trains its investigators to review CAPA and what should you do to prepare
By - Jeff Kasoff
On Demand Access Anytime
By - Jeff Kasoff
On Demand Access Anytime
Excel Spreadsheets; Ensuring Data Integrity and 21 CFR Part 11 Compliance
By - David Nettleton
Live January 21, 2025
By - David Nettleton
Live January 21, 2025
Water System Investigation "How-To's" and Example Case Studies
By - T.C Soli
On Demand Access Anytime
By - T.C Soli
On Demand Access Anytime
Solutions for Addressing Fungal and Bacterial Spore Outbreaks in Pharmaceutical, Biotech, and Medical Device Operations
By - Jim Polarine
On Demand Access Anytime
By - Jim Polarine
On Demand Access Anytime
Compliance Standards
Best Sellers
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
-
By: Miles HutchinsonAdd to CartPrice: $249
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
-
San Francisco, CA | Aug 6-7, 2020
-
Virtual Seminar | Jul 16-17, 2020
-
Virtual Seminar | Jun 18-19, 2020
-
Los Angeles, CA | Aug 20-21, 2020
-
Virtual Seminar | Jul 16-17, 2020
-
Virtual Seminar | Jun 25-26, 2020
-
Virtual Seminar | Jun 10, 2020
-
Virtual Seminar | Jun 3-4, 2020
-
Virtual Seminar | Jul 6-7, 2020
-
San Francisco, CA | Oct 22-23, 2020
-
Virtual Seminar | Jul 9-10, 2020
-
Virtual Seminar | Jun 3-4, 2020
-
Virtual Seminar | June 3-4, 2020
-
Miami, FL | Jul 29-31, 2020
-
Virtual Seminar | Jun 17, 2020
-
Provider: ANSIAdd to CartPrice: $142
- Add to Cart
- Add to Cart
- Add to Cart
-
Provider: ANSIAdd to CartPrice: $120
-
Provider: ANSIAdd to CartPrice: $250
-
Provider: SEPTAdd to CartPrice: $299
- Add to Cart
-
Provider: Quality-Control-PlanAdd to CartPrice: $37
- Add to Cart
-
Provider: At-PQCAdd to CartPrice: $397
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
You Recently Viewed